Lunai Bioworks achieves complete regression of both primary and metastatic pancreatic tumors in preclinical humanized models, marking a breakthrough in allogeneic cancer immunotherapy
Lunai Bioworks Announces Publication of Second-Generation Allogeneic Dendritic Cell Therapy Platform in the journal "Vaccines". LOS ANGELES, Nov. 6, 2025 /PRNewswire/ -- Lunai Bioworks (NASDAQ: LNAI), an AI-powered drug discovery and biodefense...
Marketplace Battle Heats Up: Trust, Convenience and Choice Key as Pricing Pressures Grow
MELBOURNE , Australia, May 22, 2025 /PRNewswire/ -- An exclusive Australian study by global ecommerce accelerator, Pattern, has shown that product range, convenience, and trustworthiness will be critical battlegrounds for online marketplaces in...
Bestqool Unveils Four-Wavelength Pro Series and Second-Gen Mobile Stand at Original Price
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- In a recent announcement, Bestqool is upgrading both the Pro100 and Pro200 to the four-wavelength configuration (630 nm, 660 nm, 850 nm, 940 nm) as the Pro 300, without increasing the price. Apart from this...